Innovation in Pharmacy Benefits that Control Cost and Provide Transparency

Prescription drug costs continue to increase at significant trends and are now approaching 25% of overall healthcare spend. Recent new innovative therapies like GLP-1 drugs for diabetes/obesity and gene therapy drugs will continue to drive pharmacy spend for plan sponsors. This presentation will explore how the prescription drug supply chain model operates and share opportunities for innovation. 

Takeaways 

1. Provide landscape overview of the prescription drug supply chain. 

2. Understand the key stakeholders in the supply chain and discuss how their business models impacts drug costs.  

3. Discuss opportunities for innovative approaches to managing drug costs and forecast where the market is heading.